This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hirai, K. Articles by Tisdale, M. J. Search for Related Content PubMed PubMed Citation Articles by Hirai, K. Articles by Tisdale, M. J.

Biological Evaluation of a Lipid-mobilizing Factor Isolated from the Urine of Cancer Patients¹

Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, United Kingdom [H. J. H., S. A. P., M. J. T.]; Department of Surgery, University of Edinburgh, Royal Infirmary, Edinburgh EH3 9YW, United Kingdom [M. D. B.]; and Department of Obstetrics and Gynecology, Osaka City University Medical School, Osaka 545-8585, Japan [K. H.]

We have previously shown human lipid-mobilizing factor (LMF) to be homologous with the plasma protein Zn-₂-glycoprotein in amino acid sequence, electrophoretic mobility, and immunoreactivity. In this study, both LMF and Zn-₂-glycoprotein have been shown to stimulate glycerol release from isolated murine epididymal adipocytes with a comparable dose-response profile. Both LMF and Zn-₂-glycoprotein caused a stimulation of adenylate cyclase in murine adipocyte plasma membranes in a GTP-dependent process, with maximum stimulation at 0.1 µM GTP and with saturation at protein concentrations of >5 µg/assay. Administration of LMF to exbreeder male mice over a 89-h period produced a decrease in body weight without a change in food and water intake. Body composition analysis showed a 42% reduction in carcass lipid when compared with controls. Treatment of ob/ob mice with human LMF over a 160-h period also produced a decrease in body weight, with a 19% reduction in carcass fat, without a change in body water or nonfat mass. Serum levels of glycerol and 3-hydroxybutyrate were significantly increased, as was oxygen uptake by interscapular brown adipose tissue, providing evidence of increased lipid mobilization and utilization. Human white adipocytes responded to both LMF and isoprenaline to the same extent, although the maximal response was lower than that for murine white adipocytes. These results suggest that LMF not only has the capacity to induce lipid mobilization and catabolism in mice, but it also has the potential to exert similar effects in cachectic cancer patients.

¹ This work was partially supported by the Osaka Medical Research Foundation for incurable disease (to K. H.) and a research studentship from Scotia Pharmaceuticals (to S. A. P.).

² To whom requests for reprints should be addressed.

Received 10/ 6/97. Accepted 4/ 1/98.

This article has been cited by other articles:

				D. M. Selva, A. Lecube, C. Hernandez, J. A. Baena, J. M. Fort, and R. Simo Lower Zinc-{alpha}2-Glycoprotein Production by Adipose Tissue and Liver in Obese Patients Unrelated to Insulin Resistance J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4499 - 4507. [Abstract] [Full Text] [PDF]

				D. C. Y. Yeung, K. S. L. Lam, Y. Wang, A. W. K. Tso, and A. Xu Serum Zinc-{alpha}2-Glycoprotein Correlates with Adiposity, Triglycerides, and the Key Components of the Metabolic Syndrome in Chinese Subjects J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2531 - 2536. [Abstract] [Full Text] [PDF]

				H. Vanni, A. Kazeros, R. Wang, B.-G. Harvey, B. Ferris, B. P. De, B. J. Carolan, R.-H. Hubner, T. P. O'Connor, and R. G. Crystal Cigarette Smoking Induces Overexpression of a Fat-Depleting Gene AZGP1 in the Human Chest, May 1, 2009; 135(5): 1197 - 1208. [Abstract] [Full Text] [PDF]

				M. J. Tisdale Mechanisms of Cancer Cachexia Physiol Rev, April 1, 2009; 89(2): 381 - 410. [Abstract] [Full Text] [PDF]

				N. Bennani-Baiti and M. P. Davis Review Article: Cytokines and Cancer Anorexia Cachexia Syndrome American Journal of Hospice and Palliative Medicine, October 1, 2008; 25(5): 407 - 411. [Abstract] [PDF]

				Md. I. Hassan, A. Waheed, S. Yadav, T. P. Singh, and F. Ahmad Zinc {alpha}2-Glycoprotein: A Multidisciplinary Protein Mol. Cancer Res., June 1, 2008; 6(6): 892 - 906. [Abstract] [Full Text] [PDF]

				O. P. Bondar, D. R. Barnidge, E. W. Klee, B. J. Davis, and G. G. Klee LC-MS/MS Quantification of Zn-{alpha}2 Glycoprotein: A Potential Serum Biomarker for Prostate Cancer Clin. Chem., April 1, 2007; 53(4): 673 - 678. [Abstract] [Full Text] [PDF]

				R. Siddiqui, D. Pandya, K. Harvey, and G. P. Zaloga Nutrition Modulation of Cachexia/Proteolysis Nutr Clin Pract, April 1, 2006; 21(2): 155 - 167. [Abstract] [Full Text] [PDF]

				M. J. Tisdale Clinical Anticachexia Treatments Nutr Clin Pract, April 1, 2006; 21(2): 168 - 174. [Abstract] [Full Text] [PDF]

				M. J. Delano and L. L. Moldawer The Origins of Cachexia in Acute and Chronic Inflammatory Diseases Nutr Clin Pract, February 1, 2006; 21(1): 68 - 81. [Abstract] [Full Text] [PDF]

				M. J. Tisdale Molecular Pathways Leading to Cancer Cachexia Physiology, October 1, 2005; 20(5): 340 - 348. [Abstract] [Full Text] [PDF]

				C. Bing, Y. Bao, J. Jenkins, P. Sanders, M. Manieri, S. Cinti, M. J. Tisdale, and P. Trayhurn Zinc-{alpha}2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia PNAS, February 24, 2004; 101(8): 2500 - 2505. [Abstract] [Full Text] [PDF]

				S. Kumar, H. Kishimoto, H. L. Chua, S. Badve, K. D. Miller, R. M. Bigsby, and H. Nakshatri Interleukin-1{alpha} Promotes Tumor Growth and Cachexia in MCF-7 Xenograft Model of Breast Cancer Am. J. Pathol., December 1, 2003; 163(6): 2531 - 2541. [Abstract] [Full Text] [PDF]

				T. Gohda, Y. Makita, T. Shike, M. Tanimoto, K. Funabiki, S. Horikoshi, and Y. Tomino Identification of Epistatic Interaction Involved in Obesity Using the KK/Ta Mouse as a Type 2 Diabetes Model: Is Zn-{alpha}2 Glycoprotein-1 a Candidate Gene for Obesity? Diabetes, August 1, 2003; 52(8): 2175 - 2181. [Abstract] [Full Text] [PDF]

				A. Inui Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management CA Cancer J Clin, March 1, 2002; 52(2): 72 - 91. [Abstract] [Full Text] [PDF]

				L. P. Hale, D. T. Price, L. M. Sanchez, W. Demark-Wahnefried, and J. F. Madden Zinc {{alpha}}-2-Glycoprotein Is Expressed by Malignant Prostatic Epithelium and May Serve as a Potential Serum Marker for Prostate Cancer Clin. Cancer Res., April 1, 2001; 7(4): 846 - 853. [Abstract] [Full Text]

				C. Bing, M. Brown, P. King, P. Collins, M. J. Tisdale, and G. Williams Increased Gene Expression of Brown Fat Uncoupling Protein (UCP)1 and Skeletal Muscle UCP2 and UCP3 in MAC16-induced Cancer Cachexia Cancer Res., May 1, 2000; 60(9): 2405 - 2410. [Abstract] [Full Text]

				K. Shinkai and R. M. Locksley Cd1, Tuberculosis, and the Evolution of Major Histocompatibility Complex Molecules J. Exp. Med., March 20, 2000; 191(6): 907 - 914. [Full Text] [PDF]

				A. Inui Cancer Anorexia-Cachexia Syndrome: Are Neuropeptides the Key? Cancer Res., September 1, 1999; 59(18): 4493 - 4501. [Abstract] [Full Text] [PDF]

				O. Ishiko, K. Hirai, S. Nishimura, T. Sumi, K.-i. Honda, M. Deguchi, I. Tatsuta, and S. Ogita Elimination of Anemia-inducing Substance by Cyclic Plasma Perfusion of Tumor-bearing Rabbits Clin. Cancer Res., September 1, 1999; 5(9): 2660 - 2665. [Abstract] [Full Text] [PDF]

				M. W. Kennedy, A. P. Heikema, A. Cooper, P. J. Bjorkman, and L. M. Sanchez Hydrophobic Ligand Binding by Zn-alpha 2-glycoprotein, a Soluble Fat-depleting Factor Related to Major Histocompatibility Complex Proteins J. Biol. Chem., September 7, 2001; 276(37): 35008 - 35013. [Abstract] [Full Text] [PDF]